Home > Boards > US Listed > Biotechs > Halozyme Therapeutics (HALO)

What do you all think of the new

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
biotechinvestor1 Member Profile
 
Followed By 0
Posts 54
Boards Moderated 0
Alias Born 02/07/16
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/17/2019 8:20:11 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/12/2019 1:41:16 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 6/7/2019 5:11:39 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/4/2019 4:45:58 PM
Halozyme To Participate In Upcoming Investor Conferences PR Newswire (US) - 6/4/2019 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/3/2019 5:24:28 PM
Halozyme Announces argenx Has Selected Second Target Under ENHANZE® Technology Collaboration And License Agreement PR Newswire (US) - 5/22/2019 1:05:00 AM
Post-effective Amendment to an S-8 Filing (s-8 Pos) Edgar (US Regulatory) - 5/14/2019 5:11:52 PM
Post-effective Amendment to an S-8 Filing (s-8 Pos) Edgar (US Regulatory) - 5/14/2019 5:08:35 PM
Halozyme To Participate In Bank of America Merrill Lynch Health Care Conference 2019 PR Newswire (US) - 5/13/2019 8:01:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/7/2019 4:14:25 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/7/2019 4:07:11 PM
Halozyme Reports First Quarter 2019 Results PR Newswire (US) - 5/7/2019 4:01:00 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 5/6/2019 4:02:13 PM
Halozyme Names Dr. Alison A. Armour As Senior Vice President Of Research And Development PR Newswire (US) - 5/6/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/3/2019 5:08:03 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/3/2019 4:30:05 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/3/2019 4:26:35 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/3/2019 4:23:56 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/3/2019 4:21:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/3/2019 4:18:26 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/3/2019 4:14:05 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/3/2019 4:11:43 PM
Halozyme To Host First Quarter 2019 Financial Results Webcast And Conference Call PR Newswire (US) - 4/23/2019 4:01:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/15/2019 4:09:46 PM
biotechinvestor1   Wednesday, 02/13/19 10:35:42 AM
Re: None
Post # of 5631 
What do you all think of the new job posted yesterday on Halo’s website (see below)

Sounds like halo wants to buy oncology assets (drug candidates or companies).

“Vice President, Oncology Business Development:

Lead execution of diligence, detailed assessment and valuation of oncology companies and assets identified as potentially attractive for Halozyme to access
Lead and execute the end-to-end M&A process, including identification of key value drivers during diligence, creation, and execution of the integration plan and monitoring and reporting of and business objectives”

https://halozyme.wd1.myworkdayjobs.com/en-US/halozymecareers/job/San-Diego/Vice-President--Corporate-Development_R0000516

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist